shRNA-targeted Cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells
Authors:
- 1 July 2008
- journal article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 317 (1-2) , 179-188
Abstract
Cyclooxygenase-2 (COX-2), one isoform of cyclooxygenase proinflammatary enzymes, is a causal factor for tumor development, invasion, metastasis, and chemoresistance. It is frequently overexpressed in a variety of human malignancies, including laryngeal carcinoma. To investigate its possibility as a therapeutic target for the treatment of laryngeal carcinoma, we employed RNA interference technology to downregulate endogenous gene COX-2 expression in laryngeal carcinoma cells and analyzed its phenotypical changes. Results showed that shRNA-mediated downregulation of COX-2 expression in human laryngeal carcinoma cells significantly inhibited cell proliferation and colony formation in vitro and reduced the potential of tumorigenicity in vivo. The specific downregulation led to cell arrest in the G0/G1 phase of cell cycle and final apoptosis induction. The increased apoptosis was associated with the ratios of Bcl-2 or Bcl-xL/Bax. In the present study, we also observed that the downregulation of COX-2 could obviously enhanced the cytotoxic effect of Taxanes both in vitro and in vivo. All these results suggest that knockdown of COX-2 expression can lead to potent antitumor activity and chemosensitizing activity to taxanes in human laryngeal carcinomas.Keywords
This publication has 28 references indexed in Scilit:
- The Effects of Cyclooxygenase-2 Expression in Prostate Cancer Cells: Modulation of Response to Cytotoxic AgentsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Quality of Life Correlates After Surgery for Laryngeal CarcinomaThe Laryngoscope, 2007
- Inhibition of COX‐2 with NS‐398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapyCell Proliferation, 2007
- Cyclooxygenases, prostanoids, and tumor progressionCancer and Metastasis Reviews, 2007
- Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cellsExperimental & Molecular Medicine, 2007
- Small interfering RNA of cyclooxygenase-2 induces growth inhibition and apoptosis independently of Bcl-2 in human myeloma RPMI8226 cellsActa Pharmacologica Sinica, 2007
- Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 yearsActa Oto-Laryngologica, 2007
- Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-κB-mediated increase of intracellular doxorubicin accumulationEuropean Journal of Cancer, 2007
- Inhibition of Cyclooxygenase (COX)-2 Expression by Tet-Inducible COX-2 Antisense cDNA in Hormone-Refractory Prostate Cancer Significantly Slows Tumor Growth and Improves Efficacy of Chemotherapeutic DrugsClinical Cancer Research, 2004
- Human ovarian surface epithelial (OSE) cells express LH/hCG receptors, and HCG inhibits apoptosis of OSE cells via up‐regulation of insulin‐like growth factor‐1International Journal of Cancer, 2000